Question 1: When working to align entries in your record and verify system to streamline data collection for use in the cancer registry, which of the following may be useful resources: |
Reference: | Commission on Cancer, Standards for Oncology Registry Entry STORE, Released 2018, American College of Surgeons
Available at https://www.facs.org/~/media/files/quality%20programs/cancer/ncdb/store_manual_2018.ashx |
Choice A: | A conversation with your hospital or state cancer registrar(s) |
Choice B: | TG263 Standardizing Nomenclatures in Radiation Oncology |
Choice C: | Standards for Oncology Registry Entry (STORE) 2018 |
Choice D: | a. and c. |
Question 2: Which section of the Commission on Cancer (CoC) consensus standardized radiation treatment summary would one use to determine the cumulative dose to the prostate in course of radiation treatment? |
Reference: | John P. Christodouleas, Nathan Anderson, Peter Gabriel, Rick Greene, Carol Hahn, Susanne Kessler, Charles S. Mayo, Todd McNutt, Lawrence N. Shulman, Benjamin D. Smith, Jeff West, Ted Williamson, A Multidisciplinary Consensus Recommendation on a Synoptic Radiation Treatment Summary: A Commission on Cancer Workgroup Report, Practical Radiation Oncology, 2020, In Press, Accessed May 21, 2020, ISSN 1879-8500
https://doi.org/10.1016/j.prro.2020.01.002. |
Choice A: | Radiation course summary |
Choice B: | Anatomic target summary |
Choice C: | Delivered prescription summary |
Choice D: | This information is not in the standardized radiation treatment summary |
Question 3: You are initiating a new clinical trial, what are the steps to encourage sharing and secondary use of data? |
Reference: | Reference: Taichman, D., Backus, J., Baethge, C., et al. Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors. N Engl J Med 374, 384-386 (2016) |
Choice A: | Secondary use will handled at the time by the researchers who wish to use the data. |
Choice B: | Data sharing is routinely open without additional requirements |
Choice C: | Data sharing plan as part of a clinical trial’s registration |
Question 4: What are the steps in a formal, controlled clinical trial data sharing request? |
Reference: | Reference: Tudur Smith, C., Hopkins, C., Sydes, M.R. et al. How should individual participant data (IPD) from publicly funded clinical trials be shared?. BMC Med 13, 298 (2015). |
Choice A: | Contact the authors of the initial publication and request direct access |
Choice B: | Complete access request, request specific data elements, include research proposal, prepare and sign data use agreement, receive data |
Choice C: | Complete access request, request all data, prepare and sign data use agreement, receive data |
Choice D: | Contact the authors, send research proposal, request all data, receive data |
Question 5: Where can AAPM members find information on which vendors have adhere to IHE RO profiles? |
Reference: | https://www.aapm.org/IHERO/default.asp |
Choice A: | Your vendor sales representative. |
Choice B: | AAPM IHE RO Website. |
Choice C: | The FDA website |
Choice D: | A and B |
Question 6: The Basic Radiotherapy Objects (BRTO II) profile specifies how to send … |
Reference: | http://www.ihe-ro.org/doku.php?id=doc:profiles |
Choice A: | CT, Structures, Dose |
Choice B: | DICOM Plans and Machine Configuration |
Choice C: | Treatment History to EMRs |
Choice D: | MLC Control Points |